| Authors: |
Rousel J; Centre for Human Drug Research (CHDR), Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Mergen C; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Schoones JW; Directorate of Research Policy, Leiden University Medical Centre, Leiden, The Netherlands., Niemeyer-van der Kolk T; Centre for Human Drug Research (CHDR), Leiden, The Netherlands., van Doorn MBA; Centre for Human Drug Research (CHDR), Leiden, The Netherlands; Department of Dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands., Bouwstra JA; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., van Smeden J; Centre for Human Drug Research (CHDR), Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research (CHDR), Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. Electronic address: rrissmann@chdr.nl. |
